Abstract
Purpose: to evaluate the #anti-arrhythmiceffect of #statins in patients receiving an implantable #cardioverter-defibrillator (ICD) for
ventricular #tachycardia/ventricular #fibrillation (VT/VF).
Methods: 85 patients with ischemic dilated cardiomyopathy
undergoing ICD implantation for sudden cardiac death (SCD) prevention
(primary prevention) were enrolled in the study. 63 patients (72%) were
on treatment with statins (group 1), and 22 were not (group 2). The
following end points were analyzed: recurrences of #ventriculararrhythmias (VA) requiring ICD intervention and mortality.
Results: after a median follow up of 46.2 months
(interquartile range 26.9 - 72.8 months) 28 patients (32.9%) had at
least one VA which
required ICD intervention. #Multivariateanalysis showed that treatment
with #statins was the only independent predictor of arrhythmic events
reduction (events requiring ICD intervention) (p=0.042). Under the 63
patients of group 1, 17 (27%) had appropriate ICD intervention, while
under the 22 patients of group 2, 11 (50%) had appropriate ICD
intervention (p=0.0185). The mortality in group 1 was 28.6% (18
patients),
while in group 2 was 50% (11 patients) (p=0.0284).
For more Biomedical open access journals please click on https://biomedres.us/
For more Research Articles on BJSTR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.